quinazolines has been researched along with Encapsulating Peritoneal Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, N; Mao, H; Qiu, A; Shi, Y; Wang, L; Xiong, C; Xu, L; Zang, X; Zhuang, S | 1 |
| Doi, S; Irifuku, T; Maeda, K; Masaki, T; Nagai, T; Nakashima, A; Ueno, T | 1 |
2 other study(ies) available for quinazolines and Encapsulating Peritoneal Sclerosis
| Article | Year |
|---|---|
Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal Fibrosis.
Topics: Animals; Disease Progression; ErbB Receptors; Gefitinib; Male; Peritoneal Fibrosis; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Time Factors; Transforming Growth Factor beta1 | 2016 |
Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis.
Topics: Animals; Azepines; Case-Control Studies; Cells, Cultured; DNA Methylation; Gene Expression Regulation, Enzymologic; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Male; Mice; Mice, Inbred C57BL; Peritoneal Fibrosis; Pyruvaldehyde; Quinazolines | 2017 |